Angústia como escuta e linguagem em Clarice Lispector
Alamedas · 06.06.2026 · 13 (2) · 51-65
DOI: 10.48075/ra.v13i2.35436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alamedas, online erschienen am 06.06.2026. Verfasst von Lara Passini Vaz-Tostes. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
This article proposes a philosophical and essayistic reading of anguish as a structure of existence and thought, based on Clarice Lispector’s chronicle “What is Anguish”. Rather than treating anguish as a pathological emotional state, this study assumes it as an ontological condition of consciousness — a space where the being contracts before the unknown, yet remains. The methodology is hermeneutic, combining literary and philosophical perspectives through an interpretive dialogue between Clarice, Søren Kierkegaard and Martin Heidegger. From Kierkegaard, the concept of anguish as the dizziness of freedom is recovered; from Heidegger, anguish as the revelation of being through the experience of nothingness. In Clarice, anguish emerges as a form of inner listening, where language bends before what it cannot yet name. The article reclaims anguish not as a failure of reason, but as the force of a thinking that emerges from the tension between absence and presence. The theoretical validity is ensured by articulating literature, existential philosophy, and phenomenology, aiming to contribute to contemporary thought on subjectivity, language, and the endurance of the human in its fragility.
Zitieren
APA
Vaz-Tostes, L. P. (2026). Angústia como escuta e linguagem em Clarice Lispector. Alamedas, 13(2), 51-65. https://doi.org/10.48075/ra.v13i2.35436
Vancouver
Vaz-Tostes LP. Angústia como escuta e linguagem em Clarice Lispector. Alamedas. 2026;13(2):51-65. doi:10.48075/ra.v13i2.35436
BibTeX
@article{VazTostes2026,
author = {Vaz-Tostes, Lara Passini},
title = {Angústia como escuta e linguagem em Clarice Lispector},
journal = {Alamedas},
year = {2026},
volume = {13},
number = {2},
pages = {51--65},
doi = {10.48075/ra.v13i2.35436}
}
EUVIMED